To an oven-dried Schlenk tube (10 mL) were charged with the α-TsG-containing peptides (0.17 mmol, 170 mol%), Zn (0.30 mmol, 300 mol%), the electrophile RX (0.10 mmol, 100 mol%, if it is a solid), and appropriate ligand (0.01 mmol, 10 mol%). Then the tube was transferred into a glove box under N2 atmosphere, to which Ni(ClO4)2•6H2O (0.01 mmol, 10 mol%), MgCl2 (0.5 mmol, 500 mol%), and tetrabutyl ammonium iodide (TBAI) (0.25 mmol, 250 mol%) were added. The tube was capped with a rubber septum and moved out of glove box. Following this, 0.2 mL of N,N-dimethylacetamide (DMA), 0.47 mL of 1,2-dime- thoxyethylene (DME) and 0.47 mL of 1,4-dioxane were added, followed by addition of RX (if the electrophile is a liquid, 0.10 mmol, 100 mol%) via syringes. The resulting mixture was allowed to stir at 25 ℃ for 12 h. Then the reaction mixture was directly loaded onto a silica gel column without work-up. The residue in the reaction vessel was rinsed with a small amount of dichloromethane (DCM) or eluent. The desired products 2a~33 were provided via flash column chromatography.
Methyl 3-((R)-1-benzamido-2-(((S)-1-methoxy-1-oxo- propan-2-yl)amino)-2-oxoethyl)benzoate (2a): White solid, 33.2 mg, 83% yield. m.p. 206~209 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.17~8.16 (m, 1H), 7.96~7.93 (m, 1H), 7.84~7.82 (m, 2H), 7.75~7.66 (m, 2H), 7.55~7.46 (m, 1H), 7.45~7.39 (m, 2H), 7.38~7.31 (m, 1H), 7.17 (d, J=7.5 Hz, 1H), 5.93 (d, J=6.7 Hz, 1H), 4.61~4.49 (m, 1H), 3.85 (s, 3H), 3.69 (s, 3H), 1.30 (d, J=7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 173.0, 169.5, 166.9, 166.7, 138.8, 133.7, 132.0, 132.0, 130.9, 129.6, 129.1, 128.7, 128.4, 127.4, 57.0, 52.7, 52.3, 48.6, 17.9; HRMS (ESI- TOF) calcd for C21H22N2O6Na [M+Na]+ 421.1376, found 421.1375.
Methyl 3-((S)-1-benzamido-2-(((S)-1-methoxy-1-oxo- propan-2-yl)amino)-2-oxoethyl)benzoate (2b): White solid, 22.6 mg, 57% yield. m.p. 200~203 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.16 (d, J=1.9 Hz, 1H), 8.00~7.93 (m, 1H), 7.87~7.78 (m, 2H), 7.73~7.65 (m, 2H), 7.55~7.46 (m, 1H), 7.45~7.37 (m, 3H), 6.89 (d, J=7.3 Hz, 1H), 5.88 (d, J=6.8 Hz, 1H), 4.62~4.50 (m, 1H), 3.87 (s, 3H), 3.64 (s, 3H), 1.39 (d, J=7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 172.7, 169.3, 166.9, 166.7, 138.4, 133.7, 132.2, 132.1, 131.0, 129.8, 129.2, 128.7, 128.6, 127.4, 57.0, 52.6, 52.3, 48.7, 18.1; HRMS (ESI-TOF) calcd for C21H22N2- O6Na [M+Na]+ 421.1376, found 421.1373.
Methyl ((R)-2-benzamido-2-(naphthalen-2-yl)acetyl)-L- alaninate (4): White solid, 26.9 mg, 69% yield. m.p. 201~204 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.00~7.95 (m, 1H), 7.86~7.82 (m, 2H), 7.79~7.69 (m, 4H), 7.57~7.54 (m, 1H), 7.51~7.47 (m, 1H), 7.46~7.39 (m, 4H), 6.94 (d, J=7.5 Hz, 1H), 6.01 (d, J=6.7 Hz, 1H), 4.64~4.52 (m, 1H), 3.70 (s, 3H), 1.29 (d, J=7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 173.0, 169.8, 166.9, 135.5, 133.9, 133.4, 133.3, 131.9, 129.2, 128.7, 128.3, 127.8, 127.4, 127.1, 126.5, 124.6, 57.6, 52.7, 48.6, 18.0; HRMS (ESI-TOF) calcd for C23H22N2O4Na [M+Na]+ 413.1477, found 413.1479.
Methyl ((R)-2-benzamido-2-(4-chlorophenyl)acetyl)-L- alaninate (5): White solid, 29.7 mg, 79% yield. m.p. 210~213 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.82~7.78 (m, 2H), 7.64 (d, J=6.7 Hz, 1H), 7.52~7.46 (m, 1H), 7.43~7.38 (m, 4H), 7.27~7.23 (m, 2H), 7.10 (d, J=7.5 Hz, 1H), 5.83 (d, J=6.7 Hz, 1H), 4.60~4.47 (m, 1H), 3.67 (s, 3H), 1.30 (d, J=7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 173.0, 169.5, 167.0, 136.7, 134.4, 133.7, 132.1, 129.2, 128.7, 127.3, 56.7, 52.7, 48.6, 18.0; HRMS (ESI-TOF) calcd for C19H19ClN2O4Na [M+Na]+ 397.0931, found 397.0934.
Methyl ((R)-2-benzamido-2-(dibenzo[b,d]furan-2- yl)acetyl)-L-alaninate (6): White solid, 38.4 mg, 89% yield. m.p. 223~226 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.12 (m, 1H), 7.89~7.80 (m, 3H), 7.70~7.67 (m, 1H), 7.62~7.58 (m, 1H), 7.54~7.48 (m, 1H), 7.47~7.36 (m, 5H), 7.22~7.17 (m, 2H), 6.09 (d, J=6.7 Hz, 1H), 4.63~4.52 (m, 1H), 3.69 (s, 3H), 1.30 (d, J=7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 173.0, 170.2, 166.9 156.6, 156.0, 133.9, 133.0, 132.0, 128.7, 127.5, 127.4, 126.2, 124.9, 123.9, 122.8, 120.9, 120.1, 112.2, 111.7, 57.3, 52.6, 48.6, 17.9; HRMS (ESI-TOF) calcd for C25H22N2O5Na [M+Na]+ 453.1426, found 453.1428.
tert-Butyl 3-((R)-1-benzamido-2-(((S)-1-methoxy-1-oxopropan-2-yl)amino)-2-oxoethyl)-9H-carbazole-9-car-boxylate (7): White solid, 47.0 mg, 89% yield. m.p. 192~194 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.18~8.07 (m, 3H), 7.98~7.86 (m, 3H), 7.65~7.57 (m, 1H), 7.55~7.49 (m, 2H), 7.47~7.39 (m, 3H), 7.36~7.30 (m, 1H), 7.09~7.04 (m, 1H), 6.24 (d, J=6.8 Hz, 1H), 4.60~4.49 (m, 1H), 3.68 (s, 3H), 1.71 (s, 9H), 1.29 (d, J=7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 173.1, 170.3, 167.0, 150.8, 138.6, 138.3, 134.0, 133.1, 131.9, 128.7, 127.4, 127.1, 126.2, 125.4, 125.2, 122.7, 119.5, 119.2, 116.7, 116.0, 83.9, 57.3, 52.6, 48.5, 28.4, 17.9; HRMS (ESI-TOF) calcd for C30H32N3O6 [M+H]+ 530.2291, found 530.2292.
Methyl ((R)-2-benzamido-2-(4-methoxyphenyl)acetyl)- L-alaninate (8): White solid, 33.0 mg, 89% yield. m.p. 215~218 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.83~7.79 (m, 2H), 7.55 (d, J=6.6 Hz, 1H), 7.52~7.46 (m, 1H), 7.43~7.38 (m, 4H), 6.88~6.82 (m, 2H), 6.73 (d, J=7.5 Hz, 1H), 5.72 (d, J=6.6 Hz, 1H), 4.63~4.51 (m, 1H), 3.77 (s, 3H), 3.71 (s, 3H), 1.32 (d, J=7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 173.0, 170.1, 166.7, 159.7, 134.0, 131.9, 130.3, 128.8, 128.6, 127.3, 114.5, 56.9, 55.4, 52.7, 48.5, 18.1; HRMS (ESI-TOF) calcd for C20H22- N2O5Na [M+Na]+ 393.1426, found 393.1428.
tert-Butyl 6-((R)-1-benzamido-2-(((S)-1-methoxy-1-oxopropan-2-yl)amino)-2-oxoethyl)-1H-indole-1-carbox- ylate (9): White solid, 41.4 mg, 86% yield. m.p. 131~134 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.06 (d, J=8.7 Hz, 1H), 7.86~7.79 (m, 2H), 7.74~7.67 (m, 2H), 7.56 (d, J=3.7 Hz, 1H), 7.53~7.45 (m, 1H), 7.44~7.38 (m, 3H), 6.95 (d, J=7.5 Hz, 1H), 6.45 (d, J=3.7 Hz, 1H), 5.93 (d, J=6.7 Hz, 1H), 4.62~4.50 (m, 1H), 3.69 (s, 3H), 1.64 (s, 9H), 1.28 (d, J=7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 173.0, 170.2, 166.7, 149.7, 135.0, 134.0, 132.6, 131.8, 131.0, 128.6, 127.3, 126.7, 123.3, 120.3, 115.8, 107.5, 84.0, 57.4, 52.6, 48.5, 28.3, 18.0; HRMS (ESI-TOF) calcd for C26H30N3O6 [M+H]+ 480.2135, found 480.2136.
Methyl ((R)-2-benzamido-2-(benzo[b]thiophen-5-yl)- acetyl)-L-alaninate (10): White solid, 21.8 mg, 55% yield. m.p. 194~197 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.98~7.94 (m, 1H), 7.85~7.81 (m, 3H), 7.68 (d, J=6.4 Hz, 1H), 7.53~7.47 (m, 1H), 7.46~7.39 (m, 4H), 7.26 (d, J=0.8 Hz, 1H), 6.67 (d, J=7.3 Hz, 1H), 5.88 (d, J=6.4 Hz, 1H), 4.64~ 4.53 (m, 1H), 3.72 (s, 3H), 1.30 (d, J=7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 173.0, 169.9, 166.8, 140.1, 139.9, 134.4, 133.9, 131.9, 128.7, 127.5, 127.3, 124.1, 123.4, 123.3, 123.0, 57.6, 52.7, 48.6, 18.1; HRMS (ESI-TOF) calcd for C21H20N2O4SNa [M+Na]+ 419.1041, found 419.1043.
Methyl ((R)-2-benzamido-2-(thiophen-3-yl)acetyl)-L- alaninate (11): White solid, 29.8 mg, 86% yield. m.p. 146~148 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.83~7.79 (m, 2H), 7.53~7.47 (m, 2H), 7.44~7.37 (m, 3H), 7.29~7.26 (m, 1H), 7.15~7.11 (m, 2H), 6.00 (d, J=7.2 Hz, 1H), 4.65~4.53 (m, 1H), 3.70 (s, 3H), 1.37 (d, J=7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 173.0, 169.5, 166.9, 138.3, 133.8, 132.0, 128.7, 127.3, 126.8, 126.4, 123.7, 53.2, 52.6, 48.6, 18.1; HRMS (ESI-TOF) calcd for C17H18N2O4SNa [M+Na]+ 369.0885, found 369.0888.
Methyl ((R)-2-benzamido-2-(6-cyanopyridin-3-yl)ace- tyl)-L-alaninate (12): White solid, 16.6 mg, 45% yield. m.p. 207~210 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.86~8.84 (m, 1H), 7.97 (dd, J=8.1, 2.3 Hz, 1H), 7.83~7.79 (m, 2H), 7.72 (d, J=6.7 Hz, 1H), 7.67~7.63 (m, 1H), 7.58~7.53 (m, 1H), 7.48~7.43 (m, 2H), 7.30 (d, J=7.5 Hz, 1H), 5.97 (d, J=6.7 Hz, 1H), 4.62~4.50 (m, 1H), 3.72 (s, 3H), 1.35 (d, J=7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 172.9, 168.1, 167.3, 150.3, 137.7, 135.9, 133.7, 132.9, 132.6, 128.9, 128.6, 127.4, 116.9, 55.0, 52.9, 48.8, 17.9; HRMS (ESI-TOF) calcd for C19H19N4O4 [M+H]+ 367.1406, found 367.1409.
Methyl ((R)-2-benzamido-2-(6-methoxypyridin-3-yl)- acetyl)-L-alaninate (13): White solid, 15.6 mg, 42% yield. m.p. 193~196 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.31~8.26 (m, 1H), 7.84~7.77 (m, 2H), 7.66 (dd, J=8.6, 2.5 Hz, 1H), 7.60 (d, J=6.7 Hz, 1H), 7.52~7.48 (m, 1H), 7.43~7.36 (m, 2H), 7.05 (d, J=7.4 Hz, 1H), 6.69 (d, J=8.6 Hz, 1H), 5.81 (d, J=6.7 Hz, 1H), 4.63~4.51 (m, 1H), 3.89 (s, 3H), 3.71 (s, 3H), 1.34 (d, J=7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 173.0, 169.5, 166.9, 164.2, 146.3, 137.6, 133.6, 132.1, 128.7, 127.3, 126.8, 111.4, 54.6, 53.7, 52.7, 48.6, 18.1; HRMS (ESI-TOF) calcd for C19H22N3O5 [M+H]+372.1559, found 372.1561.
Methyl ((R)-2-benzamido-2-(6-fluoropyridin-3-yl)-ace- tyl)-L-alaninate (14): White solid, 26.3 mg, 73% yield. m.p. 183~186 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.36~8.34 (m, 1H), 7.94~7.88 (m, 1H), 7.82~7.78 (m, 2H), 7.76 (d, J=7.0 Hz, 1H), 7.56~7.49 (m, 2H), 7.45~7.38 (m, 2H), 6.85 (dd, J=8.5, 2.9 Hz, 1H), 5.99 (d, J=6.9 Hz, 1H), 4.59~4.49 (m, 1H), 3.68 (s, 3H), 1.32 (d, J=7.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 172.9, 169.1, 167.2, 163.5 (d, J=240.7 Hz), 146.9 (d, J=15.1 Hz), 140.2 (d, J=8.1 Hz), 133.2, 132.3, 131.9 (d, J=4.7 Hz), 128.8, 127.3, 109.9 (d, J=37.5 Hz), 54.2, 52.7, 48.6, 17.9; 19F NMR (376 MHz, CDCl3) δ: -68.23; HRMS (ESI-TOF) calcd for C18H18FN3O4Na [M+Na]+ 382.1179, found 382.1182.
Methyl ((R)-2-benzamido-2-(2-phenoxypyrimidin-5-yl)- acetyl)-L-alaninate (15): White solid, 31.0 mg, 71% yield. m.p. 200~203 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.67 (s, 2H), 7.82~7.77 (m, 2H), 7.74 (d, J=6.9 Hz, 1H), 7.54~7.48 (m, 2H), 7.44~7.36 (m, 4H), 7.26~7.21 (m, 1H), 7.19~7.15 (m, 2H), 5.96 (d, J=6.9 Hz, 1H), 4.59~4.51 (m, 1H), 3.69 (s, 3H), 1.35 (d, J=7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 172.9, 168.6, 167.4, 165.3, 159.0, 152.9, 133.1, 132.4, 129.8, 128.8, 127.3, 126.6, 125.7, 121.8, 52.8, 52.6, 48.7, 17.9; HRMS (ESI-TOF) calcd for C23H23N4O5 [M+H]+ 435.1668, found 435.1672.
Methyl ((R)-2-benzamido-2-(2-fluoropyrimidin-5-yl)- acetyl)-L-alaninate (16): White solid, 17.6 mg, 49% yield. m.p. 195~198 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.78 (d, J=1.5 Hz, 2H), 7.85~7.77 (m, 2H), 7.72 (d, J=6.8 Hz, 1H), 7.57~7.51 (m, 1H), 7.47~7.41 (m, 2H), 7.33 (d, J=7.5 Hz, 1H), 5.97 (d, J=6.8 Hz, 1H), 4.58 (p, J=7.2 Hz, 1H), 3.72 (s, 3H), 1.37 (d, J=7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 173.0, 168.2 167.5, 162.9 (d, J=221.7 Hz), 160.4, 160.3, 132.8, 132.6, 130.2 (d, J=5.5 Hz), 128.9, 127.4, 52.9, 52.5 (d, J=2.1 Hz), 48.7, 18.0; 19F NMR (376 MHz, CDCl3) δ: -45.19; HRMS (ESI-TOF) calcd for C17H17FN4O4Na [M+Na]+ 383.1132, found 383.1135.
Methyl (R)-2-((S)-2-((tert-butoxycarbonyl)amino)-3-me- thylbutanamido)-2-(4-methoxyphenyl)acetate (17): White solid, 30.1 mg, 76% yield. m.p. 152~154 ℃; Major isomer: 1H NMR (400 MHz, CDCl3) δ: 7.79 (d, J=8.0 Hz, 2H), 7.52~7.40 (m, 1H), 7.34 (d, J=2.3 Hz, 2H), 5.94 (d, J=9.9 Hz, 1H), 5.05 (d, J=8.9 Hz, 1H), 4.09~3.99 (m, 1H), 3.82 (s, 3H), 2.43 (s, 3H), 2.14~2.06 (m, 1H), 1.46 (s, 9H), 0.93~0.88 (m, 3H), 0.79 (d, J=6.8 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 171.5, 163.8, 155.9, 146.0, 133.9, 130.0, 129.5, 80.5, 71.6, 59.4, 53.9, 30.6, 28.4, 21.9, 19.4, 17.1. Minor isomer: 1H NMR (400 MHz, CDCl3) δ: 7.79 (d, J=8.0 Hz, 2H), 7.52~7.40 (m, 1H), 7.34 (d, J=2.3 Hz, 2H), 5.91 (d, J=13.1 Hz, 1H), 4.91 (d, J=8.4 Hz, 1H), 4.09~3.99 (m, 1H), 3.82 (s, 3H), 2.43 (s, 3H), 2.14~2.06 (m, 1H), 1.44 (s, 9H), 0.93~0.88 (m, 3H), 0.85 (d, J=6.8 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 171.3, 163.8, 155.8, 146.0, 133.9, 130.0, 129.5, 80.3, 71.5, 59.9, 53.9, 30.4, 28.4, 21.9, 19.3, 17.5; HRMS (ESI-TOF) calcd for C20H30N2O6Na [M+Na]+ 417.2002, found 417.2007.
Methyl (R)-2-((S)-2-((tert-butoxycarbonyl)amino)-3-me- thylbutanamido)-2-(dibenzo[b,d]furan-2-yl)acetate (18): White solid, 23.6 mg, 52% yield. m.p. 163~166 ℃; Major isomer: 1H NMR (400 MHz, CDCl3) δ: 7.97~7.92 (m, 2H), 7.57~7.51 (m, 2H), 7.49~7.42 (m, 2H), 7.38~7.32 (m, 1H), 7.10 (d, J=6.4 Hz, 1H), 5.69 (d, J=6.1 Hz, 1H), 5.09~5.00 (m, 1H), 4.05~3.98 (m, 1H), 3.74 (s, 3H), 2.22~2.13 (m, 1H), 1.44 (s, 9H), 1.00 (d, J=6.7 Hz, 1H), 0.91 (d, J=6.5 Hz, 3H), 0.87 (d, J=6.8 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ: 171.4, 171.4, 171.2, 156.8, 156.2, 131.1, 127.7, 126.4, 125.0, 123.9, 123.1, 121.0, 120.0, 112.3, 111.9, 80.2, 59.9, 56.6, 53.1, 30.9, 28.4, 19.4, 17.6. Minor isomer: 1H NMR (400 MHz, CDCl3) δ: 7.97~7.92 (m, 2H), 7.57~7.51 (m, 2H), 7.49~7.42 (m, 2H), 7.38~7.32 (m, 1H), 7.06 (d, J=6.8 Hz, 1H), 5.69 (d, J=6.1 Hz, 1H), 5.09~5.00 (m, 1H), 4.05~3.98 (m, 1H), 3.74 (s, 3H), 2.22~2.13 (m, 1H), 1.41 (s, 9H), 1.00 (d, J=6.7 Hz, 1H), 0.91 (d, J=6.5 Hz, 3H), 0.87 (d, J=6.8 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ: 171.4, 171.4, 171.2, 156.8, 156.2, 131.1, 127.7, 126.4, 125.0, 123.9, 123.1, 121.0, 120.0, 112.3, 111.9, 80.2, 59.9, 56.6, 53.1, 31.0, 28.40, 19.4, 17.6; HRMS (ESI-TOF) calcd for C25H30N3O6Na [M+Na]+ 477.2002, found 477.2003.
tert-Butyl 5-((4R,7S)-7-isopropyl-11,11-dimethyl-3,6,9- trioxo-2,10-dioxa-5,8-diazadodecan-4-yl)-1H-indole-1-carboxylate (19): White solid, 29.7 mg, 59% yield. m.p. 105~109 ℃; Major isomer: 1H NMR (400 MHz, CDCl3) δ: 8.11 (d, J=8.6 Hz, 1H), 7.60 (d, J=3.7 Hz, 1H), 7.57~7.54 (m, 1H), 7.30~7.27 (m, 1H), 6.97 (d, J=6.9 Hz, 1H), 6.54 (d, J=3.7 Hz, 1H), 5.66~5.57 (m, 1H), 5.07~5.00 (m, 1H), 4.07~3.92 (m, 1H), 3.71 (s, 3H), 2.21~2.10 (m, 1H), 1.66 (s, 9H), 1.42 (s, 9H), 0.99 (d, J=6.8 Hz, 1H), 0.92~0.84 (m, 5H); 13C NMR (101 MHz, CDCl3) δ: 171.5, 171.1, 156.0, 149.7, 135.2, 131.1, 130.7, 126.9, 123.3, 120.2, 115.8, 107.4, 84.1, 80.0, 59.8, 56.7, 52.9, 31.0, 28.4, 28.3, 19.4, 17.6. Minor isomer: 1H NMR (400 MHz, CDCl3) δ: 8.11 (d, J=8.6 Hz, 1H), 7.60 (d, J=3.7 Hz, 1H), 7.57~7.54 (m, 1H), 7.30~7.27 (m, 1H), 6.91 (d, J=6.8 Hz, 1H), 6.54 (d, J=3.7 Hz, 1H), 5.66~5.57 (m, 1H), 5.07~5.00 (m, 1H), 4.07~3.92 (m, 1H), 3.71 (s, 3H), 2.21~2.10 (m, 1H), 1.66 (s, 9H), 1.43 (s, 9H), 0.99 (d, J=6.8 Hz, 1H), 0.92~0.84 (m, 5H); 13C NMR (101 MHz, CDCl3) δ: 171.5, 171.0, 156.0, 149.7, 135.2, 131.1, 130.7, 126.9, 123.3, 120.1, 115.8, 107.4, 84.1, 80.0, 59.8, 56.7, 52.9, 31.1, 28.4, 28.3, 19.4, 17.9; HRMS (ESI-TOF) calcd for C26H37N3O7Na [M+Na]+ 526.2529, found 526.2531.
Methyl (R)-2-((S)-2-((tert-butoxycarbonyl)amino)-3-me- thylbutanamido)-2-(6-fluoropyridin-3-yl)acetate (20): White solid, 22.8 mg, 59% yield. m.p. 121~124 ℃; Major isomer: 1H NMR (400 MHz, CDCl3) δ: 8.24~8.22 (m, 1H), 7.82~7.76 (m, 1H), 7.25~7.22 (m, 1H), 6.93~6.88 (m, 1H), 5.59 (d, J=6.7 Hz, 1H), 5.02~4.96 (m, 1H), 4.01~3.91 (m, 1H), 3.75 (s, 3H), 2.19~2.09 (m, 1H), 1.42 (s, 9H), 0.96 (d, J=6.8 Hz, 1H), 0.92~0.88 (m, 3H), 0.87 (d, J=6.8 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ: 171.4, 170.2, 163.6 (d, J=240.9 Hz), 156.1, 146.9 (d, J=15.3 Hz), 140.2, 130.4, 110.0 (d, J=37.7 Hz), 80.4, 60.2, 53.7, 53.4, 30.7, 28.4, 19.4, 17.7; 19F NMR (376 MHz, CDCl3) δ: -68.14. Minor isomer: 1H NMR (400 MHz, CDCl3) δ: 8.24~8.22 (m, 1H), 7.82~7.76 (m, 1H), 7.25~7.22 (m, 1H), 6.93~6.88 (m, 1H), 5.59 (d, J=6.7 Hz, 1H), 5.02~4.96 (m, 1H), 4.01~3.91 (m, 1H), 3.75 (s, 3H), 2.19~2.09 (m, 1H), 1.43 (s, 9H), 0.96 (d, J=6.8 Hz, 1H), 0.92~0.88 (m, 3H), 0.87 (d, J=6.8 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ: 171.4, 170.3, 163.6 (d, J=240.9 Hz), 156.1, 146.9 (d, J=15.3 Hz), 140.2, 130.5, 109.9 (d, J=37.8 Hz), 80.4, 60.2, 53.7, 53.4, 30.5, 28.4, 19.4, 18.0; 19F NMR (376 MHz, CDCl3) δ: -67.98; HRMS (ESI-TOF) calcd for C18H26FN3O5Na [M+Na]+ 406.1754, found 406.1757.
Methyl (R)-2-(benzo[b]thiophen-5-yl)-2-((S)-2-((tert-bu- toxycarbonyl)amino)-3-methylbutanamido)acetate (21): White solid, 27.5 mg, 65% yield. m.p. 144~147 ℃; Major isomer: 1H NMR (400 MHz, CDCl3) δ: 7.87~7.80 (m, 2H), 7.49~7.45 (m, 1H), 7.34~7.28 (m, 2H), 7.09 (d, J=6.9 Hz, 1H), 5.65 (d, J=6.7 Hz, 1H), 5.06 (d, J=8.8 Hz, 1H), 4.10~3.92 (m, 1H), 3.71 (s, 3H), 2.20~2.10 (m, 1H), 1.41 (s, 9H), 0.98 (d, J=6.8 Hz, 1H), 0.94~0.83 (m, 5H); 13C NMR (101 MHz, CDCl3) δ: 171.4, 171.2, 156.0, 140.1, 132.6, 127.7, 124.0, 123.3, 123.2, 122.7, 122.6, 80.2, 59.8, 56.6, 53.0, 30.9, 28.4, 19.4, 17.6. Minor isomer: 1H NMR (400 MHz, CDCl3) δ: 7.87~7.80 (m, 2H), 7.49~7.45 (m, 1H), 7.34~7.28 (m, 2H), 7.05 (d, J=7.0 Hz, 1H), 5.65 (d, J=6.7 Hz, 1H), 5.06 (d, J=8.8 Hz, 1H), 4.10~3.92 (m, 1H), 3.72 (s, 3H), 2.20~2.10 (m, 1H), 1.43 (s, 9H), 0.98 (d, J=6.8 Hz, 1H), 0.94~0.83 (m, 5H); 13C NMR (101 MHz, CDCl3) δ: 171.3, 171.1, 156.0, 140.1, 132.6, 127.7, 124.0, 123.3, 123.2, 122.7, 122.6, 80.2, 59.8, 56.6, 53.0, 31.0, 28.4, 19.4, 17.9; HRMS (ESI-TOF) calcd for C21H28N2O5SNa [M+Na]+ 443.1617, found 443.1618.
Methyl (6R,9S,12S)-6-(1-acetyl-1H-indol-6-yl)-12-(4- (benzyloxy)benzyl)-9-(4-(((benzyloxy)carbonyl)amino)- butyl)-2,2-dimethyl-4,7,10-trioxo-3-oxa-5,8,11-triazatri-decan-13-oate (22): White solid, 55.0 mg, 64% yield. m.p. 163~165 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.48 (s, 1H), 7.50 (d, J=8.1 Hz, 1H), 7.45~7.28 (m, 12H), 6.97 (d, J=8.2 Hz, 2H), 6.83 (d, J=8.2 Hz, 2H), 6.72 (d, J=8.0 Hz, 2H), 6.55 (d, J=3.8 Hz, 1H), 5.90 (d, J=6.5 Hz, 1H), 5.38~5.30 (m, 1H), 5.12~5.05 (m, 1H), 5.04 (s, 2H), 4.98 (s, 2H), 4.77~4.68 (m, 1H), 4.52~4.41 (m, 1H), 3.62 (s, 3H), 3.03~2.82 (m, 4H), 2.53 (s, 3H), 1.73~1.62 (m, 1H), 1.53~1.45 (m, 1H), 1.39 (s, 9H), 1.26 (s, 2H), 1.06~0.97 (m, 2H); 13C NMR (101 MHz, CDCl3) δ: 171.9, 170.9, 170.5, 168.8, 158.0, 156.5, 155.2, 137.1, 136.8, 135.7, 130.6, 130.3, 128.7, 128.6, 128.2, 128.1, 128.0, 127.7, 126.2, 122.9, 121.5, 115.6, 115.0, 108.9, 80.2, 70.0, 66.6, 59.3, 53.6, 52.9, 52.4, 40.5, 36.9, 29.8, 29.1, 28.4, 23.9, 21.9; HRMS (ESI-TOF) calcd for C48H56- N5O10 [M+H]+ 862.4027, found 862.4026.
tert-Butyl 3-((9S,12R)-9-(((S)-3-(4-(benzyloxy)phenyl)- 1-methoxy-1-oxopropan-2-yl)carbamoyl)-16,16-dimethyl-3,11,14-trioxo-1-phenyl-2,15-dioxa-4,10,13-triazaheptade-can-12-yl)-9H-carbazole-9-carboxylate (23): White solid, 66.0 mg, 68% yield. m.p. 177~181 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.29~8.24 (m, 2H), 8.01~7.98 (m, 1H), 7.93 (d, J=7.7 Hz, 1H), 7.48~7.43 (m, 2H), 7.42~7.27 (m, 11H), 6.97 (d, J=8.2 Hz, 2H), 6.85 (d, J=8.4 Hz, 2H), 6.63~6.49 (m, 2H), 5.83 (d, J=6.0 Hz, 1H), 5.35~5.28 (m, 1H), 5.03 (s, 2H), 4.98 (s, 2H), 4.88~4.82 (m, 1H), 4.79~4.71 (m, 1H), 4.47~4.35 (m, 1H), 3.64 (s, 3H), 3.06~2.81 (m, 4H), 1.73 (s, 9H), 1.70 (d, J=5.1 Hz, 2H), 1.41 (s, 9H), 1.28~1.25 (m, 2H), 1.07~0.96 (m, 2H); 13C NMR (101 MHz, CDCl3) δ: 171.9, 170.9, 170.5, 158.1, 156.6, 155.2, 151.0, 138.9, 138.5, 137.0, 136.8, 130.3, 128.7, 128.6, 128.2, 128.2, 128.1, 127.7, 127.6, 126.4, 126.2, 125.3, 123.3, 119.9, 118.7, 117.0, 116.4, 115.1, 84.3, 80.4, 70.1, 66.7, 59.1, 53.6, 52.9, 52.5, 40.3, 36.9, 29.8, 29.2, 28.5, 28.4, 21.7; HRMS (ESI-TOF) calcd for C55H64N5O11 [M+H]+ 970.4602, found 970.4604.
Methyl ((R)-2-((S)-2-((tert-butoxycarbonyl)amino)-3- methylbutanamido)-2-(9-phenyl-9H-carbazol-3-yl)acetyl)-L-valinate (24): White solid, 49.9 mg, 79% yield. m.p. 190~193 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.22~8.20 (m, 1H), 7.60 (d, J=7.5 Hz, 2H), 7.55~7.36 (m, 4H), 7.34~7.28 (m, 4H), 7.27~7.23 (m, 1H), 7.19 (d, J=8.5 Hz, 1H), 7.03~6.95 (m, 1H), 6.18 (d, J=7.1 Hz, 1H), 5.68 (d, J=9.0 Hz, 1H), 4.62~4.54 (m, 1H), 4.18~4.10 (m, 1H), 3.76 (s, 3H), 2.19~2.09 (m, 1H), 2.02~1.91 (m, 1H), 1.46 (s, 9H), 0.94 (d, J=6.6 Hz, 3H), 0.91 (d, J=6.6 Hz 3H), 0.62 (d, J=6.8 Hz, 3H), 0.59 (d, J=6.8 Hz 3H); 13C NMR (101 MHz, CDCl3) δ: 172.4, 171.2, 170.6, 156.0, 141.0, 140.5, 137.5, 130.0, 129.8, 127.4, 127.0, 126.0, 124.8, 123.5, 123.1, 120.2, 119.9, 119.8, 110.0, 109.6, 79.7, 60.2, 57.2, 57.0, 52.4, 31.7, 28.5, 19.4, 18.8, 18.1, 17.6; HRMS (ESI-TOF) calcd for C36H45N4O6 [M+H]+ 629.3339, found 629.3339.
Methyl ((R)-2-((S)-2-((tert-butoxycarbonyl)amino)-3- methylbutanamido)-2-(dibenzo[b,d]furan-2-yl)acetyl)-L-valinate (25): White solid, 25.0 mg, 45% yield. m.p. 172~175 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.00~7.99 (m, 1H), 7.62 (d, J=7.0 Hz, 1H), 7.50~7.46 (m, 1H), 7.38~7.28 (m, 5H), 7.13~7.06 (m, 1H), 6.13 (d, J=7.1 Hz, 1H), 5.67 (d, J=9.0 Hz, 1H), 4.61~4.51 (m, 1H), 4.16~4.09 (m, 1H), 3.75 (s, 3H), 2.19~2.08 (m, 1H), 2.04~1.93 (m, 1H), 1.46 (s, 9H), 0.94 (d, J=6.4 Hz, 3H), 0.91 (d, J=6.4 Hz, 3H), 0.59 (d, J=6.8 Hz, 6H); 13C NMR (101 MHz, CDCl3) δ: 172.4, 171.5, 170.2, 156.4, 156.0, 155.8, 133.1, 127.2, 125.7, 124.5, 123.7, 122.6, 120.4, 120.1, 111.8, 111.5, 79.8, 60.2, 57.1, 56.6, 52.4, 31.8, 31.6, 28.5, 19.4, 18.8, 18.0, 17.4; HRMS (ESI-TOF) calcd for C30H39N3O7Na [M+Na]+ 576.2686, found 576.2687.
tert-Butyl 2-((4S,10S)-4,10-diisopropyl-14,14-dimethyl- 3,6,9,12-tetraoxo-2,13-dioxa-5,8,11-triazapentadecan-7-yl)-9H-carbazole-9-carboxylate (26): White solid, 36.7 mg, 56% yield. m.p. 143~145 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.05~7.91 (m, 3H), 7.73 (d, J=7.2 Hz, 1H), 7.62 (d, J=9.2 Hz, 1H), 7.50 (dd, J=8.7, 1.9 Hz, 1H), 7.22 (d, J=7.9 Hz, 1H), 7.02~6.87 (m, 2H), 6.31 (d, J=7.2 Hz, 1H), 5.92 (d, J=9.2 Hz, 1H), 4.61~4.51 (m, 1H), 4.24~4.11 (m, 1H), 3.76 (s, 3H), 2.19~2.10 (m, 1H), 1.97~1.90 (m, 1H), 1.71 (s, 9H), 1.47 (s, 9H), 0.98 (d, J=5.0 Hz, 3H), 0.97 (d, J=5.0 Hz, 3H), 0.55 (d, J=6.9 Hz, 3H), 0.53 (d, J=6.6 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 172.5, 171.5, 170.4, 156.0, 150.7, 138.4, 138.2, 133.3, 126.8, 125.8, 125.1, 125.0, 122.4, 119.4, 119.0, 116.3, 115.7, 83.7, 79.6, 60.4, 57.0, 56.5, 52.4, 31.9, 29.8, 28.5, 28.5, 19.4, 18.7, 18.2, 17.4; HRMS (ESI-TOF) calcd for C35H49N4O8 [M+H]+ 653.3550, found 653.3553.
tert-Butyl 5-((4S,10S)-4,10-diisopropyl-14,14-dimethyl- 3,6,9,12-tetraoxo-2,13-dioxa-5,8,11-triazapentadecan-7-yl)-1H-indole-1-carboxylate (27): White solid, 34.3 mg, 57% yield. m.p. 134~137 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.02 (d, J=8.6 Hz, 1H), 7.58~7.56 (m, 1H), 7.53 (d, J=3.8 Hz, 1H), 7.37 (d, J=6.6 Hz, 1H), 7.29 (dd, J=8.6, 1.8 Hz, 1H), 6.66 (d, J=8.9 Hz, 1H), 6.39 (d, J=3.7 Hz, 1H), 5.74 (d, J=6.7 Hz, 1H), 5.31 (d, J=8.9 Hz, 1H), 4.55~4.50 (m, 1H), 4.09~4.01 (m, 1H), 3.73 (s, 3H), 2.12~2.05 (m, 1H), 2.04~1.97 (m, 1H), 1.64 (s, 9H), 1.42 (s, 9H), 0.89~0.81 (m, 6H), 0.67 (d, J=6.8 Hz, 3H), 0.62 (d, J=6.9 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 172.2, 171.1, 170.1, 155.9, 149.7, 135.1, 132.5, 130.9, 126.6, 123.2, 120.2, 115.7, 107.4, 83.9, 79.8, 59.9, 57.3, 57.2, 52.4, 31.6, 31.5, 28.4, 28.3, 19.3, 18.9, 17.8, 17.6; HRMS (ESI-TOF) calcd for C31H47N4O8 [M+H]+ 603.3394, found 603.3394.
Methyl (2-((S)-2-((tert-butoxycarbonyl)amino)-3-me- thylbutanamido)-2-(1-pivaloyl-1H-indol-5-yl)acetyl)-L-va- linate (28): White solid, 37.2 mg, 63% yield. m.p. 144~146 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.41 (d, J=8.7 Hz, 1H), 7.70 (d, J=3.8 Hz, 1H), 7.61~7.58 (m, 1H), 7.38~7.30 (m, 2H), 6.58 (d, J=9.0 Hz, 1H), 6.48 (d, J=3.8 Hz, 1H), 5.70 (d, J=6.6 Hz, 1H), 5.31~5.24 (m, 1H), 4.57~4.49 (m, 1H), 4.07~3.97 (m, 1H), 3.72 (s, 3H), 2.11~2.00 (m, 2H), 1.49 (s, 9H), 1.42 (s, 9H), 0.86~0.80 (m, 6H), 0.68 (d, J=6.8 Hz, 3H), 0.63 (d, J=6.9 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 177.1, 172.1, 171.1, 170.0, 155.9, 136.6, 133.4, 129.8, 126.4, 124.0, 119.9, 117.9, 108.4, 79.8, 59.9, 57.4, 57.3, 52.4, 41.3, 31.6, 31.5, 28.8, 28.4, 19.3, 18.9, 17.8, 17.6; HRMS (ESI-TOF) calcd for C31H47N4O7 [M+H]+ 587.3445, found 587.3445.
Methyl (2-(1-acetyl-1H-indol-6-yl)-2-(2-((tert-butoxy- carbonyl)amino)-3-methylbutanamido)acetyl)valinate (29): White solid, 35.3 mg, 65% yield. m.p. 181~183 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.47~8.38 (m, 1H), 7.45~7.38 (m, 3H), 7.28~7.25 (m, 1H), 6.87~6.75 (m, 1H), 6.55 (d, J=3.7 Hz, 1H), 5.77 (d, J=6.5 Hz, 1H), 5.44~5.34 (m, 1H), 4.54~4.48 (m, 1H), 4.09~4.02 (m, 1H), 3.73 (s, 3H), 2.47 (s, 3H), 2.13~2.06 (m, 1H), 2.04~1.94 (m, 1H), 1.42 (s, 9H), 0.90 (d, J=6.9 Hz, 3H), 0.86 (d, J=6.8 Hz, 3H), 0.65~0.60 (m, 6H); 13C NMR (101 MHz, CDCl3) δ: 172.2, 171.2, 169.9, 168.3, 155.9, 135.5, 135.3, 130.5, 126.1, 122.3, 121.4, 115.7, 108.7, 79.7, 59.9, 57.6, 57.3, 52.4, 31.6, 31.6, 28.4, 24.1, 19.4, 18.8, 17.8, 17.6; HRMS (ESI-TOF) calcd for C28H41N4O7 [M+H]+ 545.2975, found 545.2979.
Methyl (2-((S)-2-((tert-butoxycarbonyl)amino)-3-me- thylbutanamido)-2-(6-fluoropyridin-3-yl)acetyl)-L-valinate (30): White solid, 36.6 mg, 76% yield. m.p. 167~171 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.26~8.24 (m, 1H), 7.85~7.79 (m, 1H), 7.67~7.59 (m, 1H), 7.36 (d, J=8.9 Hz, 1H), 6.82 (dd, J=8.5, 2.9 Hz, 1H), 5.86 (d, J=7.0 Hz, 1H), 5.47 (d, J=8.7 Hz, 1H), 4.57~4.51 (m, 1H), 4.14~4.03 (m, 1H), 3.75 (s, 3H), 2.10~2.03 (m, 2H), 1.43 (s, 9H), 0.88 (d, J=3.0 Hz, 3H), 0.86 (d, J=3.1 Hz, 3H), 0.71 (d, J=5.0 Hz, 3H), 0.70 (d, J=5.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 172.4, 171.9, 169.1, 163.4 (d, J=240.6 Hz), 156.1, 146.8 (d, J=15.1 Hz), 139.9 (d, J=8.0 Hz), 132.1, 109.7 (d, J=37.7 Hz), 80.1, 60.0, 57.4, 53.9, 52.5, 31.5, 31.2, 28.4, 19.4, 18.9, 17.9, 17.7; 19F NMR (376 MHz, CDCl3) δ: -68.31; HRMS (ESI-TOF) calcd for C23H35FN4O6Na [M+Na]+ 505.2438, found 505.2440.
Methyl ((R)-2-benzamido-2-(cyclohex-1-en-1-yl)acetyl)-L-methionyl-L-phenylalaninate (31): White solid, 27.5 mg, 50% yield. m.p. 200~203 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.85~7.79 (m, 2H), 7.54~7.47 (m, 1H), 7.46~7.39 (m, 2H), 7.31~7.21 (m, 4H), 7.16~7.05 (m, 3H), 6.88 (s, 1H), 5.95 (s, 1H), 5.08 (d, J=6.6 Hz, 1H), 4.83 (q, J=7.4 Hz, 1H), 4.63 (q, J=6.9 Hz, 1H), 3.69 (s, 3H), 3.17 (dd, J=14.0, 5.5 Hz, 1H), 3.02 (dd, J=13.9, 7.4 Hz, 1H), 2.39 (h, J=14.1, 7.3 Hz, 1H), 2.33~2.23 (m, 1H), 2.09~2.03 (m, 2H), 2.00 (s, 3H), 1.99~1.84 (m, 4H), 1.61~1.46 (m, 4H); 13C NMR (101 MHz, CDCl3) δ: 171.8, 170.4, 170.3, 167.2, 135.9, 134.1, 131.9, 129.3, 129.3, 128.8, 128.7, 128.6, 127.3, 60.1, 53.5, 52.5, 52.5, 37.9, 31.2, 30.0, 25.3, 24.5, 22.4, 22.0, 15.3; HRMS (ESI-TOF) calcd for C30H38N3O5 [M+H]+ 552.2532, found 552.2531.
Methyl ((R)-2-benzamido-2-(cyclohex-1-en-1-yl)acetyl)-L-valyl-L-phenylalaninate (32): White solid, 24.0 mg, 46% yield. m.p. 205~207 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.88~7.82 (m, 2H), 7.55~7.49 (m, 1H), 7.48~7.42 (m, 2H), 7.34 (d, J=6.2 Hz, 1H), 7.25~7.22 (m, 2H), 7.21~7.18 (m, 1H), 7.10~7.05 (m, 2H), 6.49 (d, J=8.6 Hz, 1H), 6.38 (d, J=7.9 Hz, 1H), 6.07~6.01 (m, 1H), 5.02 (d, J=6.2 Hz, 1H), 4.85 (q, J=6.7 Hz, 1H), 4.23 (dd, J=8.7, 6.4 Hz, 1H), 3.71 (s, 3H), 3.15 (dd, J=14.0, 5.6 Hz, 1H), 3.06 (dd, J=13.9, 6.7 Hz, 1H), 2.16~2.00 (m, 4H), 1.86 (d, J=5.5 Hz, 1H), 1.64~1.55 (m, 4H), 0.91 (d, J=6.8 Hz, 3H), 0.85 (d, J=6.8 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 171.8, 170.3, 170.1, 166.8, 135.6, 134.7, 134.2, 131.8, 129.3, 128.8, 128.8, 128.7, 127.4, 127.3, 60.3, 58.6, 53.2, 52.6, 37.9, 31.0, 25.3, 24.1, 22.5, 22.1, 19.3, 17.8; HRMS (ESI-TOF) calcd for C22H31N2O4 [M+H]+ 520.2811, found 520.2797.
Methyl (S)-2-(2-((R)-2-benzamido-2-(cyclohex-1-en-1- yl)acetamido)acetamido)-2-phenylacetate (33): White solid, 38.0 mg, 82% yield. m.p. 210~213 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.76 (d, J=7.9 Hz, 2H), 7.70 (d, J=7.2 Hz, 1H), 7.46 (t, J=7.0 Hz, 1H), 7.37 (d, J=7.3 Hz, 2H), 7.35~7.25 (m, 6H), 7.22 (t, J=4.9 Hz, 1H), 5.95 (s, 1H), 5.56 (d, J=7.2 Hz, 1H), 5.17 (d, J=6.9 Hz, 1H), 4.08 (qd, J=17.0, 5.2 Hz, 2H), 3.64 (s, 3H), 2.11~1.93 (m, 4H), 1.64~1.45 (m, 4H); 13C NMR (101 MHz, CDCl3) δ: 171.2, 171.0, 168.2, 167.1, 136.1, 134.0, 134.0, 131.7, 129.1, 128.7, 128.5, 127.9, 127.4, 127.4, 59.7, 56.6, 52.9, 43.4, 25.2, 24.6, 22.5, 22.0; HRMS (ESI-TOF) calcd for C30H38N3O5 [M+H]+ 464.2185, found 464.2187.
Supporting Information The
1H NMR and
13C NMR spectra of compounds
2a~
33. The Supporting Information is available free of charge via the Internet at
http://sioc-journal.cn.